|
A daily dose
of aspirin appears to significantly reduce the development of
new colon polyps among people at higher risk, suggesting that
it could help lower the incidence of colorectal cancer, according
to researchers.
Two separate
studies found that taking aspirin every day reduced the chances
of developing growths that can turn into tumors among people with
a history of polyps or colon cancer.
The findings,
reported in the New England Journal of Medicine, provide the most
definitive evidence yet that the aspirin can reduce the risk for
colon cancer.
In one study,
Robert S. Sandler of the University of North Carolina in Chapel
Hill and colleagues followed 517 patients who had previously had
colon cancer. Half were given a regular 325 mg aspirin each day
and the other half received a placebo.
The study
was halted after about a year when researchers realized those
taking aspirin were about 35 percent less likely to develop new
adenomas, a type of polyp prone to turning into colon cancer.
In the other
studies, researchers found that among 1,121 patients who had previously
had polyps removed, those given a daily 81 milligram baby aspirin
had their risk of new polyps lowered by 19 percent. For reasons
the researchers could not explain, those in the group receiving
a regular 325 mg aspirin daily did not gain the same reduction
in risk..
"These
studies are very important for the field of cancer prevention,"
said Ernest T. Hawk of the National Cancer Institute. "I
would imagine there are a lot of patients that will choose to
take an aspirin to try to decrease their risk."
But an editorial
in the journal cautioned that research is continuing, and taking
aspirin cannot at this point be viewed as a magic bullet for preventing
colorectal cancer.
"Although
aspirin may be of some benefit in preventing colorectal cancer,
it cannot yet be recommended for this...and is not a substitute
for screening," wrote Dr. Thomas F. Imperiale of Indiana
University School of Medicine in Indianapolis.
Other
sources: New England Journal of Medicine
|